ANDRES PERALTA: Open Payments
NPI 1598595241 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| Ardelyx, Inc. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Procept Biorobotics Corporation | 1 | $27 |
| Medtronic, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: GEMTESA, ENTYVIO, IBSRELA, PLUVICTO, AQUABEAM ROBOTIC SYSTEM, EOHILIA, INTERSTIM, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
